NCT00951093

Brief Summary

The hypothesis of this study was that gastric bypass (GBP) ameliorates gastroesophageal reflux disease (GERD) in morbidly obese patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2007

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

August 2, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 4, 2009

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

April 4, 2014

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

5.8 years

First QC Date

August 2, 2009

Results QC Date

December 4, 2013

Last Update Submit

March 14, 2025

Conditions

Keywords

GERDGastric bypass

Outcome Measures

Primary Outcomes (7)

  • Number of Participants Presenting Reflux Symptoms

    Prevalence of typical reflux syndrome according to the Montreal Consensus. This Consensus institutes that GERD can be outlined when troublesome symptoms and/or complications induced by reflux of the gastric content back to the esophagus are present. In order to assess such troublesome symptoms a validated questionnaire translated into Portuguese language was used.

    Before GBP, 6 months after GBP and 39 months after GBP

  • Number of Participants With Esophageal Injury

    Syndromes with esophageal injury were represented exclusively by the presence of reflux esophagitis

    Before GBP, 6 months after GBP and 39 months after GBP

  • Number of Participants With Gastroesophageal Reflux Disease (GERD)

    Prevalence of GERD in patients characterized according to troublesome symptomatic syndromes assessed through a validated questionnaire based on the Montreal Consensus.

    Before GBP, 6 months after GBP and 39 months after GBP

  • Total Esophageal Acid Exposure at 24h pH Monitoring

    Esophageal acid exposure was measured through 24h pH monitoring. During the entire period, esophageal pH was measured and recorded as the percent of time pH was below 4.

    Before GBP, 6 months after GBP and 39 months after GBP

  • Esophageal Acid Exposure at 24h pH Monitoring in Upright Position

    Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in upright position

    Before GBP, 6 months after GBP and 39 months after GBP

  • Esophageal Acid Exposure at 24h pH Monitoring in Supine Position

    Esophageal acid exposure was measured through 24h pH monitoring. Esophageal pH was measured and recorded as the percent of time pH was below 4 while participant in supine position

    Before GBP, 6 months after GBP and 39 months after GBP

  • Number of Participants With Increased Acid Exposure

    Increased Acid Exposure occurs when esophageal pH is \<4 for a period longer than 4% of the total test time on a 24h pH monitoring.

    Before GBP, 6 months after GBP and 39 months after GBP

Study Arms (1)

Patients assessed for GERD

Patients who had an open gastric bypass were assessed for GERD before and after surgery following the Montreal Consensus through a validated questionnaire in Portuguese language

Procedure: Gastric bypass

Interventions

Open Silastic® ring Roux-en Y gastric bypass was performed through an upper midline incision. A gastric pouch was created by dividing the stomach with a 10-cm stapler from the lesser curvature (7 cm vertically from the cardia) to 1 cm to the left of the Hiss angle. The estimated volume of the gastric pouch was 20 to 30 ml that was banded with a 6.5 cm long Silastic® ring. A gastrojejunal anastomosis was performed with two-layers hand sewn absorbable suture over a 1.2 cm bougie distal to the ring, keeping an alimentary limb with 100 cm in length, and a biliopancreatic limb ranging 60 and 80 cm.

Patients assessed for GERD

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinic patients

You may qualify if:

  • Morbid obesity
  • Acceptance to undergo open gastric bypass

You may not qualify if:

  • Prior gastroesophageal surgery
  • Achalasia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clínica Gastrobese

Passo Fundo, Rio Grande do Sul, 99010112, Brazil

Location

Related Publications (1)

  • Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010 Feb;251(2):244-8. doi: 10.1097/SLA.0b013e3181bdff20.

MeSH Terms

Conditions

Gastroesophageal RefluxObesity, Morbid

Interventions

Gastric Bypass

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Bariatric SurgeryBariatricsObesity ManagementTherapeuticsGastroenterostomyAnastomosis, SurgicalSurgical Procedures, OperativeDigestive System Surgical Procedures

Results Point of Contact

Title
Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery
Organization
Clinica Gastrobese

Study Officials

  • Carlos AS Madalosso, PhD

    Clinica Gastrobese

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department of Metabolic and Bariatric Surgery

Study Record Dates

First Submitted

August 2, 2009

First Posted

August 4, 2009

Study Start

March 1, 2007

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

April 1, 2025

Results First Posted

April 4, 2014

Record last verified: 2025-03

Locations